Takayasu arteritis is a rare, systemic, most commonly affects women of childbearing age. It is a inflammatory large-vessel vasculitis disease involving inflammation in the walls of the largest arteries in the body: the aorta and its main branches. The disease results from an attack by the body's own immune system, causing inflammation in the walls of arteries.
The reaction was developed with p-nitrophenyl phosphate and optical density (OD) read at 405 nm with a Labsystems Multiskan MS (Helsinki, Finland). IgG anti-LPL positivity was defined for serum samples OD values above the mean OD of 20 healthy control serum samples included in each assay.
Particularly these patients needing immunosuppressive drugs. Glucocorticoids (prednisone, prednisolone or others), often referred to as “steroids,” are an important part of treatment. The dose and length of treatment depend on how bad the disease is and how long the patient has had it. Lasting damage to arteries sometimes needs a vascular procedure or surgical treatment.